HBK Sorce Advisory’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-10,956
Closed -$156K – 632
2025
Q2
$156K Sell
10,956
-1,325
-11% -$15.5K ﹤0.01% 563
2025
Q1
$129K Buy
12,281
+145
+1% +$1.64K ﹤0.01% 555
2024
Q4
$147K Sell
12,136
-507
-4% -$6.63K ﹤0.01% 551
2024
Q3
$186K Sell
12,643
-277
-2% -$3.86K 0.01% 550
2024
Q2
$186K Buy
12,920
+1,107
+9% +$17.7K 0.01% 531
2024
Q1
$192K Buy
11,813
+500
+4% +$7.82K 0.01% 563
2023
Q4
$169K Buy
+11,313
New +$128K 0.01% 535
2023
Q1
– Sell
-15,010
Closed -$183K – 673
2022
Q4
$183K Buy
+15,010
New +$187K ﹤0.01% 660
2022
Q2
– Sell
-8,360
Closed -$218K – 487
2022
Q1
$218K Buy
8,360
+522
+7% +$13.9K 0.01% 486
2021
Q4
$222K Buy
7,838
+250
+3% +$7.78K 0.01% 532
2021
Q3
$242K Buy
+7,588
New +$255K 0.01% 501

Other funds holding ELAN

HBK Sorce Advisory's ELAN Position: Q3 2025 in Review

HBK Sorce Advisory sold out of Elanco Animal Health (ELAN) in Q3 2025, closing a stake of 10,956 shares — an estimated $156K sold.

HBK Sorce Advisory first reported a position in ELAN in Q3 2021 and held it in 11 quarters. The position peaked at $242K in Q3 2021. 410 funds tracked by Wall St. Rank hold ELAN as of Q3 2025.

  • HBK Sorce Advisory reported no remaining Elanco Animal Health position as of Q3 2025 after selling out during the quarter.
  • HBK Sorce Advisory sold 10,956 Elanco Animal Health shares in Q3 2025, an estimated $156K.
  • HBK Sorce Advisory first reported a position in Elanco Animal Health in Q3 2021 and held it in 11 quarters.
  • HBK Sorce Advisory's Elanco Animal Health position peaked at $242K in Q3 2021.
  • 410 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2025.

Based on HBK Sorce Advisory's 13F filing for Q3 2025, filed 14 Oct 2025.